Details
Stereochemistry | ACHIRAL |
Molecular Formula | C11H18ClN5S |
Molecular Weight | 287.812 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CNC1=NC(N2CCN(C)CC2)=C(SC)C(Cl)=N1
InChI
InChIKey=ITYXRJDDBZMFAY-UHFFFAOYSA-N
InChI=1S/C11H18ClN5S/c1-13-11-14-9(12)8(18-3)10(15-11)17-6-4-16(2)5-7-17/h4-7H2,1-3H3,(H,13,14,15)
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL217 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11354362 |
5.4 nM [Ki] | ||
Target ID: CHEMBL214 |
430.0 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Interactions of clozapine, thioridazine, and mezilamine with oxotremorine on schedule-controlled responding. | 1983 |
|
Pharmacological characteristics of dopamine receptors involved in the dual effect of dopamine agonists on yawning behaviour in rats. | 1983 Oct 28 |
|
Suitability of amfonelic acid-induced locomotor stimulation in mice as a model for the evaluation of classical and atypical antipsychotics. | 1984 May |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6135236
Curator's Comment: Squirrel monkeys: Mezilamine (0.3 mg/kg, p.o) induced dyskinesias. https://www.ncbi.nlm.nih.gov/pubmed/6798615
Pigeons: 0.1-10 mg/kg IM
Route of Administration:
Intramuscular
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/41723
Mezilamine inhibited 3H-NA uptake into synaptosomes from
rat cortex with IC50 value of 30 uM. 10uM of mezilamine was entirely antagonized by 1 uM of clonidine.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29710
Created by
admin on Sat Dec 16 17:19:26 GMT 2023 , Edited by admin on Sat Dec 16 17:19:26 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL407641
Created by
admin on Sat Dec 16 17:19:26 GMT 2023 , Edited by admin on Sat Dec 16 17:19:26 GMT 2023
|
PRIMARY | |||
|
DTXSID20198377
Created by
admin on Sat Dec 16 17:19:26 GMT 2023 , Edited by admin on Sat Dec 16 17:19:26 GMT 2023
|
PRIMARY | |||
|
V243ORA40X
Created by
admin on Sat Dec 16 17:19:26 GMT 2023 , Edited by admin on Sat Dec 16 17:19:26 GMT 2023
|
PRIMARY | |||
|
100000081182
Created by
admin on Sat Dec 16 17:19:26 GMT 2023 , Edited by admin on Sat Dec 16 17:19:26 GMT 2023
|
PRIMARY | |||
|
3994
Created by
admin on Sat Dec 16 17:19:26 GMT 2023 , Edited by admin on Sat Dec 16 17:19:26 GMT 2023
|
PRIMARY | |||
|
68678
Created by
admin on Sat Dec 16 17:19:26 GMT 2023 , Edited by admin on Sat Dec 16 17:19:26 GMT 2023
|
PRIMARY | |||
|
SUB08937MIG
Created by
admin on Sat Dec 16 17:19:26 GMT 2023 , Edited by admin on Sat Dec 16 17:19:26 GMT 2023
|
PRIMARY | |||
|
50335-55-2
Created by
admin on Sat Dec 16 17:19:26 GMT 2023 , Edited by admin on Sat Dec 16 17:19:26 GMT 2023
|
PRIMARY | |||
|
C014287
Created by
admin on Sat Dec 16 17:19:26 GMT 2023 , Edited by admin on Sat Dec 16 17:19:26 GMT 2023
|
PRIMARY | |||
|
C66144
Created by
admin on Sat Dec 16 17:19:26 GMT 2023 , Edited by admin on Sat Dec 16 17:19:26 GMT 2023
|
PRIMARY |
ACTIVE MOIETY